Diabetes and periodontitis: The two way relationship
TLDRPeriodontitis, an inflammation of the tissues surrounding the tooth, is closely linked to diabetes mellitus. The video script explains that individuals with diabetes are at a threefold increased risk of developing periodontal disease, particularly when their diabetes is poorly controlled. The script delves into how diabetes affects the body's immune response, leading to a higher susceptibility to periodontitis due to impaired neutrophil function and increased pro-inflammatory cytokine production. It also highlights the role of advanced glycation end products (AGEs) in exacerbating periodontal damage by disrupting collagen metabolism and immune-inflammatory responses. Conversely, severe periodontitis can worsen glycemic control and increase insulin resistance, which in turn can lead to higher blood sugar levels. The script concludes by emphasizing the importance of periodontal treatment in reducing pro-inflammatory cytokines and potentially improving glycemic control in diabetic patients.
Takeaways
- π¦· **Periodontitis Definition**: Periodontitis is the inflammation of the tissues around the tooth, caused by specific bacteria and leading to the destruction of periodontal fibers and alveolar bone.
- π°οΈ **Chronic Progression**: Chronic periodontitis progresses slowly and is most common in adults, but can also affect children and adolescents.
- π **Diabetes Connection**: There is a well-established relationship between periodontal disease and diabetes, with hyperglycemia influencing the progression of periodontitis.
- π **Increased Risk for Diabetics**: Individuals with diabetes are three times more likely to develop periodontal disease, especially if their diabetes is poorly controlled.
- π¦ **Microbiota Similarity**: Research shows no significant difference in the oral microbial flora between those with and without diabetes.
- π‘οΈ **Neutrophil Dysfunction**: Diabetics have impaired neutrophil function, which can lead to a proliferation of bacteria and worsening of periodontitis.
- π₯ **Pro-Inflammatory Cytokines**: Diabetic patients often have an increased load of pro-inflammatory cytokines, leading to excessive periodontal tissue breakdown.
- π¬ **Advanced Glycation End Products (AGEs)**: AGEs, which accumulate in diabetes, can alter collagen metabolism and the immuno-inflammatory response, contributing to periodontal disease.
- π **Periodontitis Affects Diabetes**: Severe periodontitis can worsen glycemic control in diabetics and even increase the risk for non-diabetics to develop diabetes.
- π« **Insulin Resistance**: Chronic inflammation from periodontitis increases insulin resistance, making it harder for sugar to enter tissues and raising blood sugar levels.
- βοΈ **Treatment Impact**: Clinical trials have shown that periodontal treatment can reduce HbA1c levels and pro-inflammatory cytokines, potentially improving glycemic control in diabetic patients.
Q & A
What is periodontitis?
-Periodontitis is the inflammation of the supporting periodontal tissues that surround the tooth. It is caused by specific groups of micro-organisms and results in the progressive destruction of the periodontal fibers and alveolar bone.
Which type of periodontitis has a slow rate of progression and commonly affects adults and sometimes children and adolescents?
-Chronic periodontitis has a slow rate of progression and most commonly affects adults, and sometimes even children and adolescents.
How does hyperglycaemia influence the progression of periodontal disease?
-Hyperglycaemia can influence the progression of periodontal disease by affecting how periodontal tissues respond to local factors like plaque, creating an environment conducive for the development of the disease.
What is the reported risk increase for developing periodontal disease in individuals with diabetes compared to those without diabetes?
-Individuals with diabetes have a 3-fold increased risk of developing periodontal disease than individuals without diabetes.
How does diabetes affect the composition of the oral microbial flora?
-Research has shown that there is not much difference in the composition of the microbial flora in the periodontally diseased sites of individuals with and without diabetes, indicating a lack of sufficient evidence to implicate diabetes in affecting the oral microbial composition.
What is the role of neutrophils in the inflammatory response and how are they affected in diabetics?
-Neutrophils are the first line of defense during any inflammatory response, aiding in chemotaxis and migration to the inflamed site, and phagocytosing microbes or foreign bodies. However, neutrophils in diabetics have defective adherence, chemotaxis, and phagocytosis, which may lead to the survival and proliferation of microbes in the periodontal tissues, further aggravating periodontitis.
What are the effects of pro-inflammatory cytokines on periodontal tissue breakdown in diabetes patients?
-Monocytes and macrophages in diabetes patients release more than usual amounts of pro-inflammatory cytokines like TNF-Ξ± and IL-1Ξ², leading to excessive periodontal tissue breakdown.
How do advanced glycation end products (AGEs) contribute to the increased risk of periodontal disease in diabetes patients?
-AGEs can influence periodontal destruction by altering collagen metabolism and the immuno-inflammatory response. They form cross-links in collagen, making it difficult to repair or replace, and cause immune-inflammatory alterations through interaction with RAGE on inflammatory cells, leading to increased production of free radicals and pro-inflammatory cytokines.
How can severe periodontitis affect the glycaemic control of individuals with diabetes?
-Severe periodontitis can worsen the glycaemic control of diabetes patients by increasing insulin resistance, making it difficult for sugar to enter tissues and thereby increasing blood sugar levels.
What is the impact of periodontal treatment on HbA1c levels in diabetics?
-Clinical trials have shown that HbA1c levels in diabetics can reduce by 0.36% after periodontal treatment.
How does periodontal therapy potentially improve glycaemic control in patients with diabetes?
-Periodontal therapy has been shown to reduce pro-inflammatory cytokine levels in the serum, which could lead to improvements in the glycaemic control in patients with diabetes.
What is the relationship between AGEs and the immune-inflammatory response in periodontal disease?
-AGEs interact with RAGE on inflammatory cells like monocytes and macrophages, leading to an increased production of free radicals and pro-inflammatory cytokines, which contribute to periodontal destruction.
Outlines
π¦· Periodontitis and Diabetes: A Two-Way Relationship
This paragraph discusses the interplay between periodontitis, an inflammation of the tissues around the tooth, and diabetes mellitus. It explains that periodontitis is caused by certain bacteria and can lead to the destruction of periodontal fibers and alveolar bone. Chronic periodontitis is identified as a condition that progresses slowly and is more common in adults, but can also affect children and adolescents. The connection between diabetes and periodontitis is well-established, with hyperglycemia shown to influence the progression of periodontal disease. Moreover, there is evidence that chronic periodontitis can affect glycemic control and worsen diabetes complications. The increased risk for periodontal disease in individuals with diabetes is highlighted, particularly in those with poorly controlled diabetes. The role of neutrophils, monocytes, and macrophages in the inflammatory response and how diabetes can impair their function is also covered. Lastly, the accumulation of advanced glycation end products (AGEs) and their impact on collagen metabolism and the immuno-inflammatory response is discussed as a significant factor in periodontal disease risk among diabetics.
π The Impact of Periodontitis on Glycemic Control
The second paragraph explores how periodontitis can impact the glycemic control in individuals, including those with and without diabetes. It is noted that severe periodontitis can worsen glycemic control and even raise the risk for non-diabetics to develop the disease. The paragraph explains that chronic inflammation from periodontitis can increase insulin resistance, making it harder for sugar to enter tissues and thus raising blood sugar levels. The increased levels of pro-inflammatory cytokines in the saliva and gingival crevicular fluid of individuals with chronic periodontitis are shown to contribute to insulin resistance. Clinical trials have demonstrated a reduction in HbA1c levels following periodontal treatment, suggesting that periodontal therapy can reduce pro-inflammatory cytokine levels and potentially improve glycemic control in diabetic patients.
Mindmap
Keywords
π‘Periodontitis
π‘Diabetes Mellitus
π‘Hyperglycaemia
π‘Chronic Periodontitis
π‘Neutrophils
π‘Pro-inflammatory Cytokines
π‘Advanced Glycation End Products (AGEs)
π‘Glycation
π‘Receptor for Advanced Glycation End Products (RAGE)
π‘Insulin Resistance
π‘Periodontal Therapy
Highlights
Periodontitis is an inflammation of the supporting periodontal tissues surrounding the tooth, caused by specific groups of micro-organisms.
Chronic periodontitis has a slow rate of progression and commonly affects adults, sometimes even children and adolescents.
Hyperglycaemia can influence the progression of periodontal disease, and there is a growing body of evidence linking chronic periodontitis to glycaemic control and diabetes complications.
Individuals with diabetes have a 3-fold increased risk of developing periodontal disease, with poorly controlled diabetes being a significant risk factor.
Both type I and type II diabetes patients are at an increased risk of developing periodontal disease.
Poorly controlled diabetes does not directly cause periodontitis but affects how periodontal tissues respond to local factors like plaque.
There is no significant difference in the oral microbial flora composition between individuals with and without diabetes.
Neutrophils, the first line of defense during inflammation, have defective adherence, chemotaxis, and phagocytosis in diabetics, leading to increased periodontal tissue breakdown.
Diabetic patients have an increased pro-inflammatory cytokine load, with monocytes and macrophages releasing more TNF-Ξ± and IL-1Ξ².
Accumulation of advanced glycation end products (AGEs) is a major reason for increased periodontal disease risk in diabetes patients.
AGEs interfere with normal collagen metabolism, leading to the accumulation of damaged collagen that is difficult to repair or replace.
AGEs also cause immune-inflammatory alterations by interacting with receptors on inflammatory cells, increasing the production of free radicals and pro-inflammatory cytokines.
Severe periodontitis can worsen glycaemic control in diabetes patients and increase the risk for non-diabetics to develop the disease.
Chronic inflammation from periodontitis increases insulin resistance, making it difficult for sugar to enter tissues and increasing blood sugar.
The dysregulated inflammatory environment in periodontitis can aggravate insulin resistance and worsen glycaemic control.
Clinical trials have shown a reduction in HbA1c levels in diabetics after periodontal treatment.
Periodontal therapy can reduce pro-inflammatory cytokine levels in the serum, potentially improving glycaemic control in diabetes patients.
Transcripts
Browse More Related Video
5.0 / 5 (0 votes)
Thanks for rating: